P16.07 Immuno-Modulatory Effects of Ceralasertib in Combination with Durvalumab in NSCLC with Progression on Anti-PD(L)1 Treatment (HUDSON)
- Resource Type
- Abstract
- Authors
- Hernandez, M.; Besse, B.; Awad, M.; Forde, P.; Thomas, M.; Park, K.; Goss, G.; Rizvi, N.; Cosaert, J.; Szucs, Z.; Mortimer, P.; Hobson, R.; Ambrose, H.; Hayward, C.; Dressman, M.; Dean, E.; Coenen-Stass, A.; Barrett, C.; Heymach, J.; Sachsenmeier, K.
- Source
- In Journal of Thoracic Oncology March 2021 16(3) Supplement:S350-S351
- Subject
- Language
- ISSN
- 1556-0864